The Institute for Molecular Medicine Finland (FIMM) is an international research unit focusing on human genomics and personalised medicine at the Helsinki Institute of Life Science (HiLIFE) of the University of Helsinki - a leading Nordic university with a strong commitment to life science research. As part of Academic Medical Center Helsinki in Meilahti campus FIMM collaborates locally with the Faculty of Medicine, Helsinki University Hospital and National Institute for Health and Welfare. FIMM is part of the Nordic EMBL Partnership for Molecular Medicine, composed of the European Molecular Biology Laboratory (EMBL) and the centres for molecular medicine in Norway, Sweden and Denmark, and the EU-LIFE Community.

FIMM is seeking outstanding candidates for the prestigious position of

Group Leader in Molecular Medicine

This group leader search is for two early-stage group leaders with significant international experience during their PhD and postdoc periods. The selected group leaders are expected to initiate a new independent research program in one of the FIMM’s research fields.

FIMM integrates molecular medicine research, a technology centre and biobanking infrastructures under one roof, promoting translational research in grand challenge projects, specifically, the impact of genome information from the Finnish population in personalised health and medicine, individualised cancer medicine, and digital molecular medicine. The research areas of FIMM include:
• Human Genomics and Preventive Health Care
• Systems Medicine and Precision Therapeutics
Further information on the Research areas and Principal investigators can be found here:

The FIMM Technology Centre develops state-of-the-art infrastructures for genomics, medical bioinformatics, high-throughput biomedicine, metabolomics, digital and molecular pathology, single cell analysis, high-content imaging, biobanking and other translational research platforms. FIMM participates in national and international infrastructure programmes, such as BBMRI, EATRIS and EU-OPENSCREEN.

We are interested in group leader candidates who can provide novel and complementary contributions to existing research at FIMM, at HiLIFE, and at the Academic Medical Center Helsinki. The group leader appointment is initially for five years with the potential of an additional four years based on evaluation by the FIMM Scientific Advisory Board. Given an outstanding 4-year evaluation, a tenure track assistant/associate professor position may be made available at a relevant faculty of the University of Helsinki.

We are interested in candidates in the following fields: human genetics (including focus on computational genetics), systems medicine and precision medicine. One of the group leader positions is specifically supported by the Center of Excellence in Complex Disease Genetics (, a collaborative FIMM-led program of computational, statistical, experimental and registry-based research in common diseases (cardiovascular, diabetes, IBD and neuropsychiatry). The other position aims for the best candidate in any area of research relevant to the major Grand Challenge programs at FIMM.

Candidates should be able to take advantage of the infrastructure, expertise and networks available at FIMM, including translational, clinical and industrial contacts. FIMM provides a support package for the group leader, which includes salary of the group leader, support to other personnel, consumables and modern laboratory and office facilities. The candidate is expected to significantly complement this budget through other national or international grants and/or industrial collaborations.

The group leader will enjoy access to the unique infrastructures developed at FIMM (, at HiLIFE (, at the national Biocenter Finland network ( and international capabilities provided by the EMBL (

Qualification requirements include an MD/PhD, PhD or equivalent degree, postdoctoral training and a track-record of high-impact publications in the top journals in the field. International mobility, such as training in high-quality institutions and universities globally will be valued. Like a typical EMBL group leader position, the FIMM molecular medicine group leader position is intended for an early-stage independent researcher, preferably a candidate who has reached a career level equivalent to that applicable for applicants to ERC Starting Grant. We expect that the group leader will engage in multidisciplinary research collaborations with other FIMM research groups, and with the life science community in Helsinki.

Applications should include a covering letter summarizing the applicant’s career, past research accomplishments and future plans (max 2 pages), a CV and a list of publications (with 5 most significant publications indicated), a short research plan (max 5 pages) with a summary of expected translational, medical or public health impact and names of three references.

The top candidates will be invited to an interview with the international Evaluation Committee, as well as to provide a more detailed research plan and three letters of reference. We hope the new group leaders will be available to start their research at FIMM by the early 2019. ‘

To apply, please submit the application, together with your CV and a cover letter in PDF format through the University of Helsinki electronic recruitment system by clicking on the Apply link. Internal applicants (i.e., current employees of the University of Helsinki) must submit their applications through the SAP HR portal. Please apply no later than September 16, 2018.

For further information please visit our website at or contact FIMM Director Mark Daly fimm-director(at)

Information about University of Helsinki International Staff Services . In case you need support with the recruitment portal, please contact recruitment(at)

Due date

16.09.2018 23:59 EEST